SAMN29145114
External Id
dbGaP
INSDC center name
2022-06-16T10:32:13.890Z
INSDC first public
2022-07-29T02:51:19.957Z
INSDC last update
SRS13955219
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS13955219
SRA accession
RNA
analyte type
NCI_Pembrolizumab_SezarySyndrome
biospecimen repository
S9
biospecimen repository sample id
peripheral blood
body site
phs002933
gap_accession
1
gap_consent_code
GRU-COL
gap_consent_short_name
5050310
gap_sample_id
4050540
gap_subject_id
lymphocytes
histological type
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
female
sex
Clinical Trial
study design
Single-Cell RNA-Sequencing Analysis of Responses to Pembrolizumab in Sezary Syndrome
study name
S9
submitted sample id
3
submitted subject id
NCI_Pembrolizumab_SezarySyndrome
submitter handle
Tumor RNA sample from peripheral blood of a human female participant in the dbGaP study Single-Cell RNA-Sequencing Analysis of Responses to Pembrolizumab in Sezary Syndrome
title